1526-4610/asset/olbannerleft.gif?v=1&s=21f1b7d4f2c4359aaf47df570ce3e86bae828611)
1526-4610/asset/olbannerright.gif?v=1&s=457ac636b692c34a480c656754b5858bd52359be)
Migrainous Vertigo Responsive to Intravenous Methylprednisolone: Case Reports
Article first published online: 22 JUN 2009
DOI: 10.1111/j.1526-4610.2009.01474.x
© 2009 the Authors. Journal compilation © 2009 American Headache Society
Issue
Headache: The Journal of Head and Face Pain
Volume 49, Issue 8, pages 1235–1239, September 2009
Additional Information
How to Cite
Prakash, S. and Shah, N. D. (2009), Migrainous Vertigo Responsive to Intravenous Methylprednisolone: Case Reports. Headache: The Journal of Head and Face Pain, 49: 1235–1239. doi: 10.1111/j.1526-4610.2009.01474.x
Publication History
- Issue published online: 26 AUG 2009
- Article first published online: 22 JUN 2009
- Accepted for publication April 13, 2009.
- Abstract
- Article
- References
- Cited By
Keywords:
- migraine;
- dizziness;
- vertigo;
- migrainous vertigo;
- methylprednisolone
Migrainous vertigo (MV) is a newer evolving concept in which vertigo is causally related to migraine. We report 4 patients with MV. Episodes of severe MV of more than 1-day duration were successfully terminated by intravenous methylprednisolone (IV MPS) in 2 patients. Two other patients who had attacks of MV almost daily also showed complete response to IV MPS.